Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence

Cardiovascular disease (CVD) constitutes a real pandemic of the 21st century. According to data from the Centers for Disease Control and Prevention, one person dies every 34 min due to some form of CVD in the United States. Apart from the extremely high morbidity and mortality accompanying CVD, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimosiari, Athina, Patoulias, Dimitrios, Kitas, George D., Dimitroulas, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962740/
https://www.ncbi.nlm.nih.gov/pubmed/36835838
http://dx.doi.org/10.3390/jcm12041302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962740/
https://www.ncbi.nlm.nih.gov/pubmed/36835838
http://dx.doi.org/10.3390/jcm12041302

Ejemplares similares